Back تحفيز مغناطيسي للدماغ Arabic Transkranial maqnit stimulyasiyası Azerbaijani Transkranielle Magnetstimulation BAR Estimulació magnètica transcranial Catalan Transkraniel Magnetisk Stimulation Danish Transkranielle Magnetstimulation German Estimulación magnética transcraneana Spanish Transkraniaalne magnetstimulatsioon Estonian تحریک مغناطیسی مغز Persian Transkraniaalinen magneettistimulaatio Finnish
| Transcranial magnetic stimulation | |
|---|---|
 Transcranial magnetic stimulation (schematic diagram) | |
| Specialty | Psychiatry, neurology |
| MeSH | D050781 |
Transcranial magnetic stimulation (TMS) is a noninvasive form of brain stimulation in which a changing magnetic field is used to induce an electric current at a specific area of the brain through electromagnetic induction. An electric pulse generator, or stimulator, is connected to a magnetic coil connected to the scalp. The stimulator generates a changing electric current within the coil which creates a varying magnetic field, inducing a current within a region in the brain itself.[1]: 3 [2]
TMS has shown diagnostic and therapeutic potential in the central nervous system with a wide variety of disease states in neurology and mental health, but has no demonstrated clinical worth for treatment of any other condition.[3]
Adverse effects of TMS appear rare and include fainting and seizure.[4] Other potential issues include discomfort, pain, hypomania, cognitive change, hearing loss, long-lasting or permanent cognitive impairment, long-lasting anxiety and depression, panic attacks, chronic headaches and migraines, dizziness, nausea, fatigue, depersonalization and derealization, and environmental sensitivities inadvertent current induction in implanted devices such as pacemakers or defibrillators.[4][5]
- ^ NICE. January 2014 Transcranial magnetic stimulation for treating and preventing migraine
- ^ Michael Craig Miller for Harvard Health Publications. July 26, 2012 Magnetic stimulation: a new approach to treating depression?
- ^ Cite error: The named reference
updwas invoked but never defined (see the help page). - ^ a b Rossi; et al. (January 2021). "Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines". Clinical Neurophysiology. 132 (1): 269–306. doi:10.1016/j.clinph.2020.10.003. PMC 9094636. PMID 33243615. S2CID 225049093.
- ^ Hall, James (February 22, 2022). "Toxic Marketing: The Business of Selling TMS". Mad in America. Retrieved 21 November 2024.